Readers Digest
Magazine subscription Podcast

Open minded advances in healthcare from wellness innovators Medicaleaf


27th Oct 2020 Wellbeing

Open minded advances in healthcare from wellness innovators Medicaleaf

Over 200 million people in the UK and mainland Europe suffer from debilitating chronic pain, seizures and sleeping disorders as well as an equal number of increasingly enlightened people who can appreciate the recuperative benefit of cannabinoids.

There is a clear movement away from the ‘traditional’ medical practitioners and pharmaceutical companies and we aim to provide trusted and licensed products that can be bought legally and administered safely.

Public awareness and open-mindedness towards alternative cures for lifelong conditions are growing; and the World Health Organization (WHO) reports research suggesting that CBD may have therapeutic benefits for many conditions, including:

• Multiple sclerosis                

• Arthritis

• Spinal cord injury

• Epileptic seizures

• Alzheimer’s disease

• Parkinson’s disease


Research is ongoing: clinical trials to test the effectiveness of medicinal cannabis in all its forms will prove best use and lead to more government approved cannabis-based medicinal products (CBMPs) containing cannabidiol (CBD), joining those such as Epidiolex, which is already available on prescription in the UK for the treatment of seizures caused by two severe forms of epilepsy: Lennox- Gastaut syndrome and Dravet syndrome.

Medicaleaf™ was founded by a team of business leaders, marketing & technology experts, scientists, caregivers and advocates who are committed to producing safe, reliable products and promoting wellness from nature.

The widening interest in ‘wellness’ as an alternative, preventative lifestyle, particularly in these times, fuels our fire. As an organisation, we are committed to creating a business that will assist in the alleviation of pain and suffering and collaboratively create products to assist in better wellbeing and healthier living.

Medicaleaf expects to see its valuation increase fivefold before flotation in three years’ time. Medicaleaf are looking to complete their £10 million initial investment by the year end.

Capital raised will be invested in Product Manufacturing, Sales and Marketing campaigns and distribution infrastructure but will also be used for suitable acquisitions and joint ventures that will catapult the growth of the company in suitable strategic moves.

Keep up with the top stories from Reader’s Digest by subscribing to our weekly newsletter.


This post contains affiliate links, so we may earn a small commission when you make a purchase through links on our site at no additional cost to you. Read our disclaimer

Loading up next...
Stories by email|Subscription
Readers Digest

Launched in 1922, Reader's Digest has built 100 years of trust with a loyal audience and has become the largest circulating magazine in the world

Readers Digest
Reader’s Digest is a member of the Independent Press Standards Organisation (which regulates the UK’s magazine and newspaper industry). We abide by the Editors’ Code of Practice and are committed to upholding the highest standards of journalism. If you think that we have not met those standards, please contact 0203 289 0940. If we are unable to resolve your complaint, or if you would like more information about IPSO or the Editors’ Code, contact IPSO on 0300 123 2220 or visit